FAKTOR OPTIONSSCHEIN - IPSEN | Real-time BOERSE MUENCHEN 09:25:37 30/05/2024 BST | ||
| 4.24 EUR | +8.72% |
|
| Current month | -30.85% | ||
| 1 month | -32.41% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 30/05/24 | 4.24 | +8.72% |
| 29/05/24 | 3.9 | -7.80% |
| 28/05/24 | 4.23 | +5.49% |
| 27/05/24 | 4.01 | +16.23% |
| 24/05/24 | 3.45 | -5.99% |
Real-time BOERSE MUENCHEN
Last update May 30, 2024 at 09:25 am
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Goldman Sachs |
| WKN | GG3BNR |
| ISIN | DE000GG3BNR4 |
| Date issued | 01/02/2024 |
| Strike | 142.6 € |
| Maturity | Unlimited |
| Parity | 5.62 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.3 € |
|---|---|
| Lowest since issue | 3.45 € |
| Spread | 0.05 € |
| Spread % | 1.16% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.33%
- Stock Market
- Certificates
- Certificat
